Study links small pancreas size to faster progression to stage 3 type 1 diabetes

by Vanderbilt University Medical CenterGraphical Abstract. Credit:Diabetes Care(2023). DOI: 10.2337/dc23-1681A multicenter, longitudinal study, co-led by investigators at the Vanderbi

Updated on: March 14,2024 20

Study links small pancreas size to faster progression to stage 3 type 1 diabetes

by Vanderbilt University Medical CenterGraphical Abstract. Credit:Diabetes Care(2023). DOI: 10.2337/dc23-1681A multicenter, longitudinal study, co-led by investigators at the Vanderbi

Updated on:March 14,2024 20

Glycemic control and predicting diabetes complications in older adults

by Chigoziri Konkwo,Yale UniversityCredit: Unsplash/CC0 Public DomainHemoglobin A1c (HbA1c) level plays an important role in type 2 diabetes (T2D) treatment, serving as an important indicator of

Updated on: March 14,2024 19

Glycemic control and predicting diabetes complications in older adults

by Chigoziri Konkwo,Yale UniversityCredit: Unsplash/CC0 Public DomainHemoglobin A1c (HbA1c) level plays an important role in type 2 diabetes (T2D) treatment, serving as an important indicator of

Updated on:March 14,2024 19

Diabetes risk in overweight, obese teens varies substantially by baseline HbA1c

by Lori SolomonCredit: Unsplash/CC0 Public DomainFive-year diabetes risk among teens with overweight or obesity varies substantially by baseline HbA1c levels, according to a studypublished

Updated on: March 14,2024 13

Diabetes risk in overweight, obese teens varies substantially by baseline HbA1c

by Lori SolomonCredit: Unsplash/CC0 Public DomainFive-year diabetes risk among teens with overweight or obesity varies substantially by baseline HbA1c levels, according to a studypublished

Updated on:March 14,2024 13

Study finds increased body and abdominal fat cause insulin resistance in teenagers, raising type 2 diabetes risk

by University of Eastern FinlandBoth total body fat mass and abdominal fat cause hyperglycemia, hyperinsulinemia, and insulin resistance, with abdominal fat doubling the risk of metabolic dysfunc

Updated on: March 14,2024 8

Study finds increased body and abdominal fat cause insulin resistance in teenagers, raising type 2 diabetes risk

by University of Eastern FinlandBoth total body fat mass and abdominal fat cause hyperglycemia, hyperinsulinemia, and insulin resistance, with abdominal fat doubling the risk of metabolic dysfunc

Updated on:March 14,2024 8

New DNA methylation-based method for precise assessment of pancreas cell composition

by Hebrew University of JerusalemHistological image of the human pancreas, stained with antibodies against insulin (green) and glucagon (red), together marking an islet of Langerhans. Blue labels

Updated on: March 14,2024 7

New DNA methylation-based method for precise assessment of pancreas cell composition

by Hebrew University of JerusalemHistological image of the human pancreas, stained with antibodies against insulin (green) and glucagon (red), together marking an islet of Langerhans. Blue labels

Updated on:March 14,2024 7

AI model provides a hypoglycemia early warning system when driving

by Ludwig Maximilian University of MunichControlled hypoglycemia procedures for studies 1 and 2 used variable insulin and glucose administration with corresponding driving sessions in euglycemia

Updated on: March 14,2024 14

AI model provides a hypoglycemia early warning system when driving

by Ludwig Maximilian University of MunichControlled hypoglycemia procedures for studies 1 and 2 used variable insulin and glucose administration with corresponding driving sessions in euglycemia

Updated on:March 14,2024 14

High out-of-pocket costs hindering treatment of diabetes

by University of MichiganHigh out-of-pocket costs hindering treatment of diabetes. Credit: Jacob Dwyer/Michigan MedicineActively managing diabetes is crucial to preventing long-term health compli

Updated on: March 14,2024 13

High out-of-pocket costs hindering treatment of diabetes

by University of MichiganHigh out-of-pocket costs hindering treatment of diabetes. Credit: Jacob Dwyer/Michigan MedicineActively managing diabetes is crucial to preventing long-term health compli

Updated on:March 14,2024 13

Patients had to lobby for correct diabetes diagnoses: Was their race a reason?

by Bram Sable-Smith, KFF Health NewsCredit: Christina Morillo from PexelsWhen Phyllisa Deroze was told she had diabetes in a Fayetteville, North Carolina, emergency department years ago, she was hande

Updated on: March 14,2024 17

Patients had to lobby for correct diabetes diagnoses: Was their race a reason?

by Bram Sable-Smith, KFF Health NewsCredit: Christina Morillo from PexelsWhen Phyllisa Deroze was told she had diabetes in a Fayetteville, North Carolina, emergency department years ago, she was hande

Updated on:March 14,2024 17

Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

by University of Eastern FinlandTransition of patients between contact types by usual in-person service use frequency groups Groups based on in-person contact during 16 Mar 2017 to 15 Mar 2020: A

Updated on: March 14,2024 13

Diverging effects of the COVID-19 pandemic on type 2 diabetes care processes

by University of Eastern FinlandTransition of patients between contact types by usual in-person service use frequency groups Groups based on in-person contact during 16 Mar 2017 to 15 Mar 2020: A

Updated on:March 14,2024 13

For diabetes and liver cancer, study suggests new screening guidelines

by Krista Conger,Stanford University Medical CenterCollagen fibers in a three-dimensional hydrogel (left panel). When advanced glycation end products—a byproduct of poorly controlled diabetes—ar

Updated on: March 14,2024 14

For diabetes and liver cancer, study suggests new screening guidelines

by Krista Conger,Stanford University Medical CenterCollagen fibers in a three-dimensional hydrogel (left panel). When advanced glycation end products—a byproduct of poorly controlled diabetes—ar

Updated on:March 14,2024 14

Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes

by Delthia Ricks , Medical XpressTeplizumab delays type 1 diabetes (T1D) in at-risk individuals in TN10 trial, but participants respond differently to the treatment. Systemic, non-pathogenic antibody

Updated on: March 14,2024 20

Gut microbes may determine patients' response to a drug that delays onset of type 1 diabetes

by Delthia Ricks , Medical XpressTeplizumab delays type 1 diabetes (T1D) in at-risk individuals in TN10 trial, but participants respond differently to the treatment. Systemic, non-pathogenic antibody

Updated on:March 14,2024 20

Under-the-skin implant could treat type I diabetes

by David Nutt,Cornell UniversityDesign of the SHEATH system.a, Schematic illustrating the creation of the vascularized subcutaneous site achieved by implantation of a catheter 4–6 weeks be

Updated on: March 14,2024 12

Under-the-skin implant could treat type I diabetes

by David Nutt,Cornell UniversityDesign of the SHEATH system.a, Schematic illustrating the creation of the vascularized subcutaneous site achieved by implantation of a catheter 4–6 weeks be

Updated on:March 14,2024 12